| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 1704-1713 |
| Journal | Multiple Sclerosis |
| Volume | 20 |
| Issue number | 13 |
| DOIs | |
| Publication status | Published - 2014 |
Cite this
}
The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosis. / Barkhof, F.; Jong, R.; Sfikas, N.; de Vera, A.; Francis, G.; Cohen, J.
In: Multiple Sclerosis, Vol. 20, No. 13, 2014, p. 1704-1713.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosis
AU - Barkhof, F.
AU - Jong, R.
AU - Sfikas, N.
AU - de Vera, A.
AU - Francis, G.
AU - Cohen, J.
PY - 2014
Y1 - 2014
U2 - 10.1177/1352458514532317
DO - 10.1177/1352458514532317
M3 - Article
VL - 20
SP - 1704
EP - 1713
JO - Multiple Sclerosis
JF - Multiple Sclerosis
SN - 1352-4585
IS - 13
ER -